Taiho Expands Cancer Pipeline With ADCs In $400m Araris Buy

Add-On To Japanese Pharma’s Small Molecule Efforts

 
• By Mandy Jackson
  
Araris and Taiho first partnered on ADC development in November 2023 (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Scrip